Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Extension Study for Patients Previously Enrolled in a Genentech/Roche Trial
2022-003414-36Phase 3Active
- Sponsor
- Roche
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ipatasertib, sponsored by Roche. Started Jan 2023; status: active.
02
Drugs
ipatasertib
Beyond the preview
Go deeper on 2022-003414-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003414-36.